Emiel Rossing

4PUBLICATIONS
18CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMedical biochemistry - carbohydrates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 14, 2024
Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells.

Emily Archer Goode, Margarita Orozco-Moreno, Kirsty Hodgson

|Jan 08, 2024
Two Receptor Binding Strategy of SARS-CoV-2 Is Mediated by Both the N-Terminal and Receptor-Binding Spike Domain.

Michele Monti, Edoardo Milanetti, Myrthe T Frans

|Oct 17, 2023
Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors.

Margarita Orozco-Moreno, Eline A Visser, Kirsty Hodgson

|Dec 03, 2021
Fluorinated rhamnosides inhibit cellular fucosylation.

Johan F A Pijnenborg, Emiel Rossing, Jona Merx

Pageof 1

Frequent Collaborators

3 joint publications

Thomas J Boltje

2 joint publications

Johan F A Pijnenborg

2 joint publications

Jennifer Munkley

1 joint publications

Marek J Noga